Interestingly, S100A8 and S100A9, whose products form the heterocomplex calprotectin, are strongly up-regulated in our study (Table 1), in agreement with reports on inflammation-associated cancer and in human colorectal carcinomas [34,35]. The gene discussed is S100A8; the disease is cancer.